Abselion is delighted to announce the appointment of Dr Anne Jones to the board of the company as non-executive director. Anne brings over 25 years of global commercial experience in the Life Sciences, Healthcare and Cell Therapy arenas working with world class corporations to drive business strategy and operational excellence.
Anne is President and CEO of G-CON Manufacturing, Inc., an innovator in cleanrooms for biopharmaceutical processing and other advanced technologies, having previously held the positions of CBO at Celularity Inc., a next-gen cellular medicines company, and COO at Genuity Science, where world leading genomics and machine learning was applied to map the causal biology of disease.
Prior to this Anne served in VP/ General Manager roles driving significant business growth at Danaher Corporation, Agilent Technologies and GE Healthcare.
As well as her wealth of commercial experience, Anne has a PhD in Cancer Research with a focus on protein and molecular biology.
“I am pleased to welcome Anne to the Abselion Board. As we enter the next phase of commercial growth, Anne’s experience and track-record will be invaluable as we execute our goal to simplify protein quantification for the scientists making crucial decisions to accelerate the development of biotherapeutics.” Ruizhi Wang, CEO.
“I am very excited to support the Abselion team. The technology they have developed is innovative and cutting edge, with a range of applications that will help to progress biological research in a meaningful and controlled way.”